GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3576 - 3600 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgG Patient 2 24 mild
G96865DJ
37
IgG Patient 2 3 mild
G82348BZ
37
IgG Patient 2 3 mild
G86566MF
37
IgG Patient 3 -180 mild
G25473LQ
37
IgG Patient 3 -180 mild
G38488WF
37
IgG Patient 3 4 mild
G17390SF
37
IgG Patient 3 4 mild
G63074CQ
37
IgG Patient 1 22 moderate
G03499BP
36
IgG Patient 1 22 moderate
G21675ZL
36
IgG Patient 1 22 moderate
G31265MS
36
IgG Patient 1 22 moderate
G84224TW
36
IgG Patient 1 6 moderate
G03499BP
36
IgM Patient 1 10 moderate
G17266GE
36
IgM Patient 1 10 moderate
G84224TW
36
IgM Patient 1 22 moderate
G82204SH
36
IgM Patient 1 6 moderate
G00052MO
36
IgM Patient 1 6 moderate
G25473LQ
36
IgG Patient 2 15 mild
G08520NM
36
IgG Patient 2 15 mild
G40696TO
36
IgG Patient 2 15 mild
G86566MF
36
IgG Patient 2 3 mild
G82204SH
36
IgG Patient 3 -180 mild
G21320TF
36
IgG Patient 3 11 mild
G00053MO
36
IgG Patient 3 11 mild
G39213VZ
36
IgG Patient 3 4 mild
G29857RC
36

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024